when does the patent on semaglutide expire Indian pharma launches low-cost Ozempic generics as expires The patent for semaglutide in

Adherence Analysis: Semaglutide QW Versus Other GLP-1 RAs As a result of the relatively short period of time from the launch of semaglutide QW to the index date, fewer patients receiving semaglutide QW were included in the adherence analysis at both 180 and 360 days ( n = 447 and n = 87, respectively), compared with patients receiving dulaglutide ( n = 17,073 and n = 7280, respectively) (Table 2), liraglutide ( n = 11,996 and n = 6137, respectively), and exenatide QW ( n = 5842 and n = 2683, respectively)

Strict adherence to your doctor's dose-escalation schedule is essential

Van Orden, K., Giebler, H

This info is useful to discuss with your doctor at follow-ups